Publication | Closed Access

HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-β-d-glucuronide in human plasma

MedicineBioanalysisMass SpectrometryAntiviral Drug DevelopmentAntiviral TherapyHuman PlasmaAnalytical ChemistryHplc-ms/ms MethodClinical ChemistryAntiviral DrugPharmacologyChromatographySimultaneous QuantificationDrug Analysis